"World's Most Complete Market Research Reports Repository"

Global Antidiabetic Drugs Market Size, Status and Forecast 2025

This report studies the global Antidiabetic Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Antidiabetic Drugs market by companies, region, type and end-use industry.

In 2017, the global Antidiabetic Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
Eli Lilly
Novartis
Boehringer Ingelheim
Merck
Novo Nordisk
Sanofi
AstraZeneca
Takeda
Bayer
Pfizer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Oral Drugs
Injectable Drugs

Market segment by Application, split into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others

The study objectives of this report are:
To study and forecast the market size of Antidiabetic Drugs in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetic Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antidiabetic Drugs Manufacturers
Antidiabetic Drugs Distributors/Traders/Wholesalers
Antidiabetic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antidiabetic Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Antidiabetic Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Antidiabetic Drugs
1.1 Antidiabetic Drugs Market Overview
1.1.1 Antidiabetic Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Antidiabetic Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Antidiabetic Drugs Market by Type
1.3.1 Oral Drugs
1.3.2 Injectable Drugs
1.4 Antidiabetic Drugs Market by End Users/Application
1.4.1 Type 1 Diabetes
1.4.2 Type 2 Diabetes
1.4.3 Gestational Diabetes Mellitus
1.4.4 Others

2 Global Antidiabetic Drugs Competition Analysis by Players
2.1 Antidiabetic Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Eli Lilly
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.4 Merck
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.5 Novo Nordisk
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.6 Sanofi
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.7 AstraZeneca
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.8 Takeda
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.9 Bayer
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)
3.10 Pfizer
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Antidiabetic Drugs Revenue (Million USD) (2013-2018)

4 Global Antidiabetic Drugs Market Size by Type and Application (2013-2018)
4.1 Global Antidiabetic Drugs Market Size by Type (2013-2018)
4.2 Global Antidiabetic Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Antidiabetic Drugs in Future
4.4 Top Consumer/End Users of Antidiabetic Drugs

5 United States Antidiabetic Drugs Development Status and Outlook
5.1 United States Antidiabetic Drugs Market Size (2013-2018)
5.2 United States Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Antidiabetic Drugs Market Size by Application (2013-2018)

6 Europe Antidiabetic Drugs Development Status and Outlook
6.1 Europe Antidiabetic Drugs Market Size (2013-2018)
6.2 Europe Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Antidiabetic Drugs Market Size by Application (2013-2018)

7 China Antidiabetic Drugs Development Status and Outlook
7.1 China Antidiabetic Drugs Market Size (2013-2018)
7.2 China Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Antidiabetic Drugs Market Size by Application (2013-2018)

8 Japan Antidiabetic Drugs Development Status and Outlook
8.1 Japan Antidiabetic Drugs Market Size (2013-2018)
8.2 Japan Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Antidiabetic Drugs Market Size by Application (2013-2018)

9 Southeast Asia Antidiabetic Drugs Development Status and Outlook
9.1 Southeast Asia Antidiabetic Drugs Market Size (2013-2018)
9.2 Southeast Asia Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Antidiabetic Drugs Market Size by Application (2013-2018)

10 India Antidiabetic Drugs Development Status and Outlook
10.1 India Antidiabetic Drugs Market Size (2013-2018)
10.2 India Antidiabetic Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Antidiabetic Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Antidiabetic Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Antidiabetic Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Antidiabetic Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Antidiabetic Drugs Market Size by Application (2018-2025)

12 Antidiabetic Drugs Market Dynamics
12.1 Antidiabetic Drugs Market Opportunities
12.2 Antidiabetic Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Antidiabetic Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Antidiabetic Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Global Antidiabetic Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Antidiabetic Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Antidiabetic Drugs Market Share by Regions (2013-2018)
Figure United States Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Antidiabetic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Antidiabetic Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Antidiabetic Drugs Revenue Market Share by Type in 2017
Figure Oral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Injectable Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Antidiabetic Drugs Market Share by Application in 2017
Figure Antidiabetic Drugs Market Size (Million USD) and Growth Rate in Type 1 Diabetes (2013-2018)
Figure Antidiabetic Drugs Market Size (Million USD) and Growth Rate in Type 2 Diabetes (2013-2018)
Figure Antidiabetic Drugs Market Size (Million USD) and Growth Rate in Gestational Diabetes Mellitus (2013-2018)
Figure Antidiabetic Drugs Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Antidiabetic Drugs Market Size Share by Players in 2013
Figure Antidiabetic Drugs Market Size Share by Players in 2017
Table Eli Lilly Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Novo Nordisk (2013-2018)
Figure Novo Nordisk Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Takeda Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Takeda (2013-2018)
Figure Takeda Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Bayer Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Antidiabetic Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Antidiabetic Drugs Business Revenue Market Share (2013-2018)
Table Global Antidiabetic Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Antidiabetic Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Antidiabetic Drugs Market Share by Product in 2017
Table Global Antidiabetic Drugs Market Size by Application (2013-2018)
Figure Global Antidiabetic Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Antidiabetic Drugs
Figure United States Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Antidiabetic Drugs Market Size Share by Players in 2013
Figure United States Antidiabetic Drugs Market Size Share by Players in 2017
Table United States Antidiabetic Drugs Market Size by Application (2013-2018)
Figure United States Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Antidiabetic Drugs Market Size Share by Application in 2017
Figure Europe Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Antidiabetic Drugs Market Size Share by Players in 2013
Figure Europe Antidiabetic Drugs Market Size Share by Players in 2017
Table Europe Antidiabetic Drugs Market Size by Application (2013-2018)
Figure Europe Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Antidiabetic Drugs Market Size Share by Application in 2017
Figure China Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Antidiabetic Drugs Market Size Share by Players in 2013
Figure China Antidiabetic Drugs Market Size Share by Players in 2017
Table China Antidiabetic Drugs Market Size by Application (2013-2018)
Figure China Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Antidiabetic Drugs Market Size Share by Application in 2017
Figure Japan Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Antidiabetic Drugs Market Size Share by Players in 2013
Figure Japan Antidiabetic Drugs Market Size Share by Players in 2017
Table Japan Antidiabetic Drugs Market Size by Application (2013-2018)
Figure Japan Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Antidiabetic Drugs Market Size Share by Application in 2017
Figure Southeast Asia Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Antidiabetic Drugs Market Size Share by Players in 2013
Figure Southeast Asia Antidiabetic Drugs Market Size Share by Players in 2017
Table Southeast Asia Antidiabetic Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Antidiabetic Drugs Market Size Share by Application in 2017
Figure India Antidiabetic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Antidiabetic Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Antidiabetic Drugs Market Size Share by Players in 2013
Figure India Antidiabetic Drugs Market Size Share by Players in 2017
Table India Antidiabetic Drugs Market Size by Application (2013-2018)
Figure India Antidiabetic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Antidiabetic Drugs Market Size Share by Application in 2017
Figure Global Antidiabetic Drugs Market Size and Growth Rate (2018-2025)
Table Global Antidiabetic Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Antidiabetic Drugs Market Size Share (2018-2025)
Figure Global Antidiabetic Drugs Market Size Share by Regions in 2025
Figure United States Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Antidiabetic Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Antidiabetic Drugs Market Size Share by Type in 2018
Figure Global Antidiabetic Drugs Market Size Share by Type in 2025
Table Global Antidiabetic Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Antidiabetic Drugs Market Size (Million USD) by Application in 2018

Choose License Type